Insulin |
|
A10AB
|
Insulins and analogues for injection, fast acting |
A10AB01–A10AB03
|
Insulin (human/beef/pork) |
A10AB04–A10AB06
|
Insulin analogues (lispro/aspart/glulisine) |
A10AC
|
Insulins and analogues for injection, intermediate acting |
A10AC01–A10AC03
|
Insulin human/beef/pork |
A10AC04
|
Insulin analogue (lispro) |
A10AD
|
Insulins and analogues for injection, intermediate acting combined with fast acting |
A10AD01–A10AD03
|
Insulin (human/beef/pork) |
A10AD04–A10AD05
|
Insulin analogues (lispro/aspart) |
A10AE
|
Insulins and analogues for injection, long acting |
A10AE01–A10AE03
|
Insulin (human/beef/pork) |
A10AE04–A10AE05
|
Insulin glargine/detemir |
Oral anti-diabetic drugs |
|
A10BA
|
Biguanides |
A10BB
|
Sulfonamides, urea derivatives |
A10BC
|
Sulfonamides (heterocyclic) |
A10BD
|
Combinations of oral blood-glucose-lowering drugs |
A10BF
|
α-Glucosidase inhibitors |
A10BG
|
Thiazolidinediones |
A10BH
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors |
A10BX
|
Other blood-glucose-lowering drugs, excluding insulins |